Oseltamivir/Pimodivir

奥司他韦/吡莫地韦

Report date: 2023/05/15 10:54:54
NME

Base Information

Drug NameOseltamivir/Pimodivir
Drug Alias NamePimodivir/OseltamivirPimodivir+Oseltamivir PhosphatePimodivir/Oseltamivir PhosphateOseltamivir+PimodivirPimodivir+Oseltamivir
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitorsPolymerase basic protein 2 inhibitors
TargetsNeuraminidasePolymerase basic protein 2
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes PimodivirOseltamivir Phosphate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A